<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p72" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_72{left:130px;bottom:1196px;letter-spacing:-0.15px;}
#t2_72{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_72{left:141px;bottom:1104px;letter-spacing:-0.01px;}
#t4_72{left:248px;bottom:1104px;letter-spacing:0.25px;}
#t5_72{left:143px;bottom:1047px;letter-spacing:-0.29px;}
#t6_72{left:250px;bottom:1067px;letter-spacing:-0.01px;}
#t7_72{left:267px;bottom:1038px;}
#t8_72{left:294px;bottom:1038px;letter-spacing:-0.01px;}
#t9_72{left:294px;bottom:1019px;letter-spacing:-0.01px;}
#ta_72{left:267px;bottom:990px;letter-spacing:-0.01px;}
#tb_72{left:250px;bottom:962px;letter-spacing:0.21px;}
#tc_72{left:248px;bottom:926px;letter-spacing:-0.04px;}
#td_72{left:141px;bottom:855px;letter-spacing:-0.01px;}
#te_72{left:248px;bottom:855px;letter-spacing:0.12px;}
#tf_72{left:141px;bottom:823px;letter-spacing:0.22px;}
#tg_72{left:250px;bottom:818px;letter-spacing:-0.01px;}
#th_72{left:250px;bottom:799px;letter-spacing:-0.01px;}
#ti_72{left:250px;bottom:779px;letter-spacing:-0.01px;}
#tj_72{left:250px;bottom:760px;letter-spacing:-0.01px;}
#tk_72{left:143px;bottom:775px;}
#tl_72{left:141px;bottom:704px;letter-spacing:-0.03px;}
#tm_72{left:248px;bottom:704px;letter-spacing:-0.03px;}
#tn_72{left:141px;bottom:657px;letter-spacing:-0.3px;}
#to_72{left:248px;bottom:630px;letter-spacing:0.09px;}
#tp_72{left:141px;bottom:558px;letter-spacing:-0.01px;}
#tq_72{left:248px;bottom:558px;letter-spacing:-0.01px;}
#tr_72{left:141px;bottom:527px;letter-spacing:0.22px;}
#ts_72{left:250px;bottom:522px;letter-spacing:-0.01px;}
#tt_72{left:250px;bottom:502px;letter-spacing:-0.01px;}
#tu_72{left:250px;bottom:483px;letter-spacing:-0.01px;}
#tv_72{left:584px;bottom:483px;}
#tw_72{left:595px;bottom:483px;letter-spacing:-0.01px;}
#tx_72{left:250px;bottom:463px;letter-spacing:-0.01px;}
#ty_72{left:250px;bottom:444px;letter-spacing:-0.01px;}
#tz_72{left:250px;bottom:425px;letter-spacing:-0.01px;}
#t10_72{left:143px;bottom:479px;}
#t11_72{left:250px;bottom:377px;letter-spacing:-0.01px;}
#t12_72{left:250px;bottom:357px;letter-spacing:-0.01px;}
#t13_72{left:141px;bottom:321px;letter-spacing:-0.03px;}
#t14_72{left:248px;bottom:321px;letter-spacing:-0.03px;}
#t15_72{left:141px;bottom:274px;letter-spacing:-0.3px;}
#t16_72{left:248px;bottom:247px;letter-spacing:-0.04px;}
#t17_72{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_72{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_72{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_72{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_72{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_72{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_72{font-size:10px;font-family:NotoSans-Regular_7j-;color:#000;}
.s6_72{font-size:8px;font-family:NotoSans-Regular_7j-;color:#000;}
.s7_72{font-size:9px;font-family:NotoSans-Regular_7j-;color:#000;}
.s8_72{font-size:13px;font-family:NotoSansMath-Regular_7k6;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts72" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

@font-face {
	font-family: NotoSansMath-Regular_7k6;
	src: url("fonts/NotoSansMath-Regular_7k6.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg72Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg72" style="-webkit-user-select: none;"><object width="908" height="1286" data="72/72.svg" type="image/svg+xml" id="pdf72" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_72" class="t s0_72">7.3. Fundamental considerations of multimodal therapy approaches </span><span id="t2_72" class="t s1_72">72 </span>
<span id="t3_72" class="t s2_72">7.38. </span><span id="t4_72" class="t s0_72">Consensus-based recommendation </span>
<span id="t5_72" class="t s3_72">EEC </span>
<span id="t6_72" class="t s2_72">Postoperative radiochemotherapy should </span>
<span id="t7_72" class="t s4_72">- </span><span id="t8_72" class="t s2_72">at R1 or resection margin &lt;5mm in the mucosa in the tumor parts not surrounded </span>
<span id="t9_72" class="t s2_72">by cartilage or </span>
<span id="ta_72" class="t s2_72">-with extracapsular tumor growth in the lymph nodes </span>
<span id="tb_72" class="t s0_72">take place. </span>
<span id="tc_72" class="t s5_72">Strong consensus: 100% </span>
<span id="td_72" class="t s2_72">7.39. </span><span id="te_72" class="t s1_72">Evidence-based recommendation </span>
<span id="tf_72" class="t s6_72">Recommendation level </span>
<span id="tg_72" class="t s2_72">If adjuvant chemoradiotherapy is indicated, it should be administered with a simultaneous </span>
<span id="th_72" class="t s2_72">cisplatin-containing regimen in patients with an increased risk of tumor recurrence </span>
<span id="ti_72" class="t s2_72">(resection margin &lt;5 mm in the mucosa and in the tumor parts not surrounded by cartilage </span>
<span id="tj_72" class="t s2_72">and/or extracapsular tumor growth). </span>
<span id="tk_72" class="t s3_72">B </span>
<span id="tl_72" class="t s5_72">Level of Evidence </span><span id="tm_72" class="t s5_72">[234-237] </span>
<span id="tn_72" class="t s3_72">1b </span>
<span id="to_72" class="t s7_72">Consensus: 86% </span>
<span id="tp_72" class="t s2_72">7.40. </span><span id="tq_72" class="t s2_72">Evidence-based recommendation </span>
<span id="tr_72" class="t s6_72">Recommendation level </span>
<span id="ts_72" class="t s2_72">Postoperative radiotherapy should be conventionally fractionated and administered at </span>
<span id="tt_72" class="t s2_72">average risk (lymph node level with affected lymph nodes without capsule perforation and </span>
<span id="tu_72" class="t s2_72">the region of the former primary tumor with resection </span><span id="tv_72" class="t s8_72">≥ </span><span id="tw_72" class="t s2_72">5 mm in sano) with 54-60 Gy in </span>
<span id="tx_72" class="t s2_72">27-30 fractions over 5.5-6 weeks and at stages with increased risk of recurrence (region of </span>
<span id="ty_72" class="t s2_72">the former primary tumor with resection &lt;5mm in sano and the region of the lymph nodes </span>
<span id="tz_72" class="t s2_72">with evidence of extracapsular growth) with 66 Gy in 33 fractions over 6.5 weeks </span>
<span id="t10_72" class="t s3_72">B </span>
<span id="t11_72" class="t s2_72">In elective lymph node irradiation, the dose should be between 45 Gy and 54 Gy, </span>
<span id="t12_72" class="t s2_72">depending on the risk, with single doses of 1.5 to 2.0 Gy. </span>
<span id="t13_72" class="t s5_72">Level of Evidence </span><span id="t14_72" class="t s5_72">[208, 209, 234-236] </span>
<span id="t15_72" class="t s3_72">1b </span>
<span id="t16_72" class="t s5_72">Strong consensus: 100% </span>
<span id="t17_72" class="t s0_72">© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
